Thursday, May 10, 2018 5:50:35 AM
5/8/2018 Cantor Fitzgerald Set Price Target Buy $16.00
https://www.marketbeat.com/stocks/NASDAQ/NBRV/
Nabriva Therapeutics’ (NBRV) Buy Rating Reiterated at Needham & Company LLC
Posted by Faye Duncan on May 10th, 2018 // No Comments
Nabriva Therapeutics logoNabriva Therapeutics (NASDAQ:NBRV)‘s stock had its “buy” rating reissued by stock analysts at Needham & Company LLC in a research report issued to clients and investors on Tuesday. They currently have a $18.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s price target indicates a potential upside of 282.98% from the stock’s previous close.
The analysts wrote, “Nabriva reported 1Q18 financial results today and we spoke w/ mgmt for an update. Mgmt reiterated guidance for top-line results from the second of two Phase 3 trials of lead antibiotic lefamulin in Community Pneumonia (CABP) in 2Q18. We continue to expect a positive outcome and reiterate BUY rating. We believe the opportunity for lefamulin in Community Pneumonia is misunderstood and underappreciated by investors. We acknowledge challenges for antibiotics within the hospital, but believe oral lefamulin can be relevant in the large outpatient community setting.””
https://dakotafinancialnews.com/2018/05/10/nabriva-therapeutics-nbrv-buy-rating-reiterated-at-needham-company-llc.html
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM